13 Tue
All-day
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
11:50 am Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall
Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall
Aug 13 @ 11:50 am – 12:12 pm
Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall | Vallikavu | Kerala | India
V. Nagaraja Ph.D. Professor, Indian Institute of Science, Bengaluru, India Perturbation of DNA topology in mycobacteria To maintain the topological homeostasis of the genome in the cell, DNA topoisomerases catalyse DNA cleavage, strand passage and rejoining of the ends. Thus,
3:55 pm Delegate Talk: Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on Pyrimido[5,4-e][1,2,4]triazine derivatives as PLK 1 inhibitors @ Sathyam Hall
Delegate Talk: Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on Pyrimido[5,4-e][1,2,4]triazine derivatives as PLK 1 inhibitors @ Sathyam Hall
Aug 13 @ 3:55 pm – 4:10 pm
Delegate Talk: Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on Pyrimido[5,4-e][1,2,4]triazine derivatives as PLK 1 inhibitors @ Sathyam Hall | Vallikavu | Kerala | India
Rajasekhar Chekkara, Venkata Reddy Gorla and Sobha Rani Tenkayala Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on Pyrimido[5,4-e][1,2,4]triazine derivatives as PLK 1 inhibitors Polo-like kinase 1 (PLK1) is a significant enzyme with diverse biological actions in cell cycle progression,
5:06 pm Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall
Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall
Aug 13 @ 5:06 pm – 5:27 pm
Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall | Vallikavu | Kerala | India
Bodo Eickhoff, Ph.D. Senior Vice-President, Head of Sales and Marketing for Roche Applied Science, Germany New paths for treatment of complex diseases: target combinatorial drug therapy Several types of diseases show a complex pathogenesis and require targeted as well as